F

Fidelity Investments

Manages investments and workplace retirement plans

Vice President - Institutional Support

Full-TimeUpdated on 10/22/2026
No salary listed
Expert
Bachelor's
Smithfield, RI, USA
In PersonFidelity is transitioning to full-time onsite work through a phased rollout; onsite expectations vary by role and location and may evolve.
Sales & Account ManagementSales Operations
No H1B Sponsorship

About the job

Requirements
  • At least 10 years of relevant work experience in sales, service, client management, project or program management, marketing, or financial services.
  • A bachelor's degree is required.
  • Strong consultative, listening, communication, and analytical skills.
  • Interpersonal skills to work effectively across the organization at all management and peer levels.
  • Demonstrated leadership, influence, and collaboration in a matrix-managed environment and across diverse groups.
  • Experience across functional business areas such as client, operations, systems, marketing, finance, investments, and customer service.
  • Willingness and ability to experiment with new approaches, track progress, and incorporate lessons from failure.
  • Ability to analyze multiple data points to develop strategic recommendations.
  • A track record of successfully managing multiple sizable, complex, cross-functional projects or initiatives.
  • Understanding of Fidelity Institutional and Fidelity businesses and how the Institutional Client Group fits into the broader ecosystem.
Responsibilities
  • Develop and implement business strategies and execution plans with the Head of Institutional Client Group and the Leadership Team to achieve sales and financial targets aligned with Asset Management goals.
  • Work across Asset Management and Fidelity Institutional functional groups to support business goals and objectives.
  • Develop strong partnerships with the Heads of Institutional Client Group, Sales and Relationship Management, and Consultant Relations.
  • Manage a team of associates within the Market Enablement group.
  • Influence the strategic planning process in support of Institutional Client Group business goals.
  • Manage and execute segmentation, client and prospect coverage, sales and marketing execution plan integration, Consultant Relations business planning, customer relationship management processes, infrastructure support, and go-to-market strategies.
  • Provide input into business decisions that affect the strategic direction of the distribution organization.
  • Consult with business partners to define requirements for business initiatives, the channel scorecard, extended-team measurement, reporting, and progress monitoring.
  • Align with functional partners in Product, Strategy, Marketing, Technology, and Finance to implement Fidelity Asset Management Services Institutional Client Group and Asset Management initiatives.
  • Provide project leadership and oversight.
Desired Qualifications
  • General knowledge of Fidelity Institutional Asset Management and Fidelity Asset Management Services product lines and vehicle types.
  • Series 7, 63, and 24 licenses are desired but not required.

About the company

Fidelity Investments manages money and runs brokerage accounts for individuals, while administering workplace benefits and supporting financial advisers and institutions. Its funds span active management and index investing, and its advice services range from automated portfolios to dedicated wealth managers. Customers trade through online accounts or work with advisers by phone and at investor centers, while employers use its services for retirement savings and stock plans. The business earns advisory fees and charges for selected trades, with institutional custody and clearing services alongside its consumer accounts. Fidelity was founded in 1946 and is headquartered in Boston, Massachusetts, United States.

Company Size

10,001+

Company Stage

Debt Financing

Total Funding

$247.8B

Headquarters

Boston, Massachusetts

Founded

1946

Get referred to Fidelity Investments

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Growth supports business investment: March 2026 reporting showed Fidelity's 2025 revenue rose 15% to $37.7 billion.
  • Eligible US employees build retirement savings: Fidelity combines a 401(k) match with annual profit sharing.
  • Investment teams gained product scope: Fidelity launched four active small and midcap ETFs in April 2026.

What critics are saying

  • Technology careers face restructuring: Fidelity cut about 800 jobs in its technology and product overhaul in May 2026.
  • Boston staff face less flexibility: April 2026's policy sets five office days from September, with phone-support exemptions.
  • Custody teams face irreversible errors: Fidelity's bitcoin fund warns lost private keys without backups permanently strand assets.

What makes Fidelity Investments unique

  • Public shareholders do not set Fidelity's agenda: the investment group remains privately held.
  • Fidelity competes on fund costs: its four ZERO index mutual funds charge no expense ratio.
  • Platform scale supports large projects: Fidelity reported $18 trillion under administration for year-end 2025 in March 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Mental Health Support
  • Hybrid Work Options
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Unlimited Paid Time Off
  • Parental Leave
  • Student Loan Assistance
  • Tuition Reimbursement

Company News

Yahoo Finance
Oct 22nd, 2026
Fidelity's Timmer says AI bubble risk lies in debt, as CoreWeave bond yields top 15%

Fidelity's director of global macro, Jurrien Timmer, says any AI bubble may sit in debt markets rather than stocks. Yields on bonds from AI cloud provider CoreWeave topped 15% last week, even as equity valuations fall. Timmer compared CoreWeave's yield with a Bloomberg index of junk-rated telecom bonds from the 1998 to 2000 boom. In that era, the warning came from debt, not dot-com stocks. Highly rated AI borrowers still look stable, he said. CoreWeave's 2031 notes yielded 15.78% last Thursday. Its debt rose from $21 billion at the end of 2025 to $35 billion by June 30, and net interest expense of $640 million took about a quarter of second-quarter revenue. Chief executive officer Mike Intrator said its backlog, near $104 billion, more than covers its debt.

Business Wire
Oct 16th, 2026
Newsroom | Business Wire

The global leader in press release distribution and regulatory disclosure. Public relations and investor relations professionals rely on Business Wire for broad-based and targeted market reach.

IT桔子
Oct 15th, 2026
Veir raises $24.9M Series A+ for high-temperature superconductor power transmission

US startup Veir has raised $24.9 million in a Series A+ round. VXI Capital, Galvanize Climate Solutions, Fidelity Investments, Congruent Ventures, The Engine, and Breakthrough Energy Ventures invested. Veir develops a way to transmit electricity using high-temperature superconductors (HTS). Its platform uses evaporative cryogenic cooling. The technology lets utilities carry more power at lower voltage within a smaller right-of-way. This helps connect the lowest-cost renewable resources to the places that need them.

Business Wire
Oct 13th, 2026
Inscripta Announces the First Commercial Shipment of Its Onyx™ Digital Genome Engineering Platform and Closes $150 Million in New Financing

Financing round led by Fidelity and T. Rowe Price funds underscores vast opportunities to bring Inscripta’s technology to the broader bioeconomy.

Morningstar
Oct 13th, 2026
Soufflé Therapeutics raises $135M Series B led by Juvia Group for muscle and heart RNA therapies

Soufflé Therapeutics has closed an oversubscribed $135 million Series B round led by Juvia Group. New investors include TCG Crossover Management, BB Biotech, Fidelity Management & Research Company, Balyasny Asset Management, and a sovereign wealth fund. Existing backers such as Amgen Ventures, ARCH Venture Partners, and Temasek also took part. The RNA therapies company will use the money to move its three lead programs into clinical studies. They target facioscapulohumeral muscular dystrophy (FSHD), heart failure with reduced ejection fraction, and muscle and metabolic disorders. It will also advance its pipeline in other cell types and tissues. Its REMEDY (Receptor Mediated Delivery) engine delivers oligonucleotide therapies to specific cells outside the liver. "This exceptional group of investors" backs the engine's potential, said chief executive officer Amir Nashat.